Eculizumab Is An Effective Long-Term Treatment In Patients with Atypical Hemolytic Uremic Syndrome (aHUS) Previously Receiving Chronic Plasma Exchange/Infusion (PE/PI): Extension Study Results,
暂无分享,去创建一个
C. Bedrosian | A. Trivelli | C. Licht | C. Legendre | C. Loirat | P. Muus | K. Douglas | T. Goodship | Y. Delmas | M. Herthelius | M. Hourmant